From application‐first to science‐first: A two‐phase validation framework for complex <i>in vitro</i> <scp>NAMs</scp>

Yiguang Zhu, Paul A. Locke

Open source

DOI
10.1002/cpt.70428
Published
2026-08-03
Container
Clinical Pharmacology &amp; Therapeutics
Publisher
Wiley
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1002/cpt.70428,
  title = {From application‐first to science‐first: A two‐phase validation framework for complex
                    <i>in vitro</i>
                    <scp>NAMs</scp>},
  author = {Yiguang Zhu and Paul A. Locke},
  year = {2026},
  journal = {Clinical Pharmacology \&amp; Therapeutics},
  doi = {10.1002/cpt.70428},
  url = {https://doi.org/10.1002/cpt.70428}
}

RIS

TY  - JOUR
TI  - From application‐first to science‐first: A two‐phase validation framework for complex
                    <i>in vitro</i>
                    <scp>NAMs</scp>
AU  - Yiguang Zhu
AU  - Paul A. Locke
PY  - 2026
JO  - Clinical Pharmacology &amp; Therapeutics
DO  - 10.1002/cpt.70428
UR  - https://doi.org/10.1002/cpt.70428
ER  - 

APA

Zhu, Y., & Locke, P. A. (2026). From application‐first to science‐first: A two‐phase validation framework for complex <i>in vitro</i> <scp>NAMs</scp>. Clinical Pharmacology &amp; Therapeutics. https://doi.org/10.1002/cpt.70428

Source records